Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 4/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | PHGDH | O43175 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11390900 | 0.86 | TDP1 (0.41) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL29398719 | 0.75 | TAAR1 (0.42) | TSHRALDH1A1MEN1HTTKMT2A | |
| SCHEMBL14088328 | 0.75 | CYP3A4 (0.36) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL5062802 | 0.75 | TDP1 (0.36) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL322574 | 0.74 | TDP1 (0.45) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL2153928 | 0.73 | — | — | |
| Trimethylammonium SCHEMBL8734959 | 0.71 | TDP1 (0.75) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL9508241 | 0.71 | CYP3A4 (0.47) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL230096 | 0.69 | TDP1 (0.53) | TDP1CYP3A4ESR1ESR2TSHR | |
| SCHEMBL11664569 | 0.69 | TDP1 (0.53) | TDP1CYP3A4ESR1ESR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12440830-B2 | Ligands for production of 1-octene in chromium assisted ethylene oligomerization process | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-14 | — | — | US | disclosed |
| US-11925927-B2 | Ligands for production of 1-octene in chromium assisted ethylene oligomerization process | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2024-03-12 | — | — | US | disclosed |
| EP-3880360-B1 | LIGANDS FOR PRODUCTION OF 1-OCTENE IN CHROMIUM ASSISTED ETHYLENE OLIGOMERIZATION PROCESS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-04-05 | — | — | EP | disclosed |
| US-20230053092-A1 | Ligands for Production of 1-Octene in Chromium Assisted Ethylene Oligomerization Process | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-02-16 | — | — | US | disclosed |
| US-11511265-B2 | Ligands for production of 1-octene in chromium assisted ethylene oligomerization process | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-11-29 | — | — | US | disclosed |
| US-20220152602-A1 | LIGANDS FOR PRODUCTION OF 1-OCTENE IN CHROMIUM ASSISTED ETHYLENE OLIGOMERIZATION PROCESS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2022-05-19 | — | — | US | disclosed |
| EP-3941892-A1 | LIGANDS FOR PRODUCTION OF 1-OCTENE IN CHROMIUM ASSISTED ETHYLENE OLIGOMERIZATION PROCESS | SABIC Global Technologies B.V. (NL) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12440830-B2 | Ligands for production of 1-octene in chromium assisted ethylene oligomerization process | AP1M1, OR10J3, OXER1 | TDP1 663/4885CYP3A4 1588/4885ESR1 38/4885 |
| US-20220152602-A1 | LIGANDS FOR PRODUCTION OF 1-OCTENE IN CHROMIUM ASSISTED ETHYLENE OLIGOMERIZATION PROCESS | AP1M1, OR10J3, OXER1 | TDP1 663/4885CYP3A4 1588/4885ESR1 38/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.